USD
EUR
in stock
Simparica Trio Chewable Tablet for Dogs, 5.6-11.0 lbs, (Purple Box)
Details
Specifications
Help your furry friend fight off pests with Simparica Trio Chewable Tablets for Dogs! Every purchase comes with 6 treatments that are specially formulated for canine companions 8 weeks of age and older, weighing between 5.6 and 11 pounds. Simparica Trio is the first and only product that combines sarolaner, moxidectin and pyrantel in each treatment to help prevent heartworm disease, kill fleas before they can lay eggs, kill 5 types of ticks, treat and prevent flea infestations and treat and control roundworms and hookworms. And each monthly chewable tablet has a palatable liver flavor and can be taken with or without food!\n\n**Proudly sourced directly from the manufacturer or their approved distributor. Guaranteed genuine and backed by the manufacturer.**
| Item Number | 224817 |
|---|---|
| For Use With | Dogs |
| Generic Name | sarolaner, moxidectin, and pyrantel (as pamoate salt). |
| Administration Form | Oral |
| Common Brand Name(s) | Simparica Trio |
| Usage | Prevention, Treatment |
| Kills or Treats | Fleas, Ticks, Roundworms, Hookworms |
| Repels or Prevents | Heartworms, Fleas |
| Lifestage | Adult, Puppy |
| Breed Size | Small Breeds |
| Product Form | Chewable Tablet |
| Strength | 6 mg Sarolaner, 0.12 mg Moxidectin, 25 mg Pyrantel |
| Health Condition | Heartworms, Ticks, Fleas, Roundworms, Hookworms |
| Drug Type | Parasiticide |
Uses
Monthly Simparica Trio prevents heartworm disease, kills adult fleas and is indicated for the treatment and prevention of flea infestations, the treatment and control of tick infestations, and the treatment and control of roundworm and adult hookworm infections in dogs and puppies 8 weeks of age and older, and weighing 2.8 pounds or greater.
Possible Side Effects
The most frequently reported adverse reactions in clinical trials were vomiting and diarrhea.
Drug & Food Interactions
There are no known contraindications for the use of SIMPARICA TRIO.
Precautions
Not for use in humans. Keep this and all drugs out of reach of children. Use with caution in dogs with a history of seizures. Simparica Trio contains sarolaner, a member of the isoxazoline class, which has been associated with neurologic adverse reactions including tremors, ataxia, and seizures in dogs with or without a history of neurologic disorders. The safe use of Simparica Trio has not been evaluated in breeding, pregnant, or lactating dogs. The most frequently reported adverse reactions in clinical trials were vomiting and diarrhea.
Ingredients
sarolaner, moxidectin, and pyrantel (as pamoate salt).
Instructions
Recommended Dosage
This medication should be administered orally at monthly intervals. Consult your veterinarian for proper dosing instructions.
Storage Instructions
Store at or below 30°C (86°F).
